Printer Friendly

U.S. ALCOHOL TESTING SUBSIDIARY SIGNS LETTER OF INTENT FOR FIRM COMMITMENT INITIAL PUBLIC OFFERING

 RANCHO CUCAMONGA, Calif., July 1 /PRNewswire/ -- Gary S. Wolff, chief financial officer of U.S. Alcohol Testing of America Inc. (AMEX: AAA), announced today that the company has signed a letter of intent for an initial public offering of $7.5 million of the shares of common stock of its wholly owned subsidiary, U.S. Drug Testing Inc.
 The company will offer 1,500,000 shares at approximately $5 per share, representing a 30 percent equity interest. The shares will be underwritten on a firm commitment basis, and will be offered only by means of a prospectus. The company expects to file a registration statement with the Securities and Exchange Commission in the near future.
 U.S. Alcohol Testing transferred all assets related to its drug testing operations, including all intellectual property, to U.S. Drug Testing on Jan. 1, 1993. The company has recently received three pre- marketing approvals from the Food and Drug Administration for: the Flow Immunoassay System Model 9000; the assay which detects cocaine and its metabolite benzoylecgonine; and the assay which detects opiates, including heroin and morphine.
 The purpose of this offering is to allow U.S. Drug Testing to continue the research and development of the flow immunosensor technology licensed to the company by the United States Naval Research Laboratory, through a Cooperative Research and Development Agreement with the Naval Research Laboratory.
 U.S. Alcohol Testing of America Inc. manufactures screening and evidential alcohol breath-testing equipment or use by law enforcement agencies and industry.
 -0- 7/1/93
 /CONTACT: Gary S. Wolff, CFO of U.S. Alcohol Testing of America, 909-466-8378/
 (AAA)


CO: U.S. Alcohol Testing of America Inc.; U.S. Drug Testing Inc. ST: California IN: HEA SU: OFR

MF-JL -- LA015 -- 7526 07/01/93 08:30 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 1, 1993
Words:296
Previous Article:AIRSENSORS INC. REPORTS INCREASED SALES AND FOURTH CONSECUTIVE QUARTER OF PROFITABILITY
Next Article:ZEOS INTERNATIONAL ANNOUNCES AVAILABILITY OF ENERGY EFFICIENT PERSONAL COMPUTERS
Topics:


Related Articles
PHOENIX LASER SYSTEMS ANNOUNCES TERMINATION OF NEGOTIATIONS WITH STORZ INSTRUMENT COMPANY
SUBSIDIARY OF U.S. ALCOHOL TESTING FILES WITH SECURITIES AND EXCHANGE COMMISSION FOR INITIAL PUBLIC OFFERING
U.S. ALCOHOL TESTING OF AMERICA INC. ANNOUNCES INCREASED REVENUES AND DECREASED LOSSES
U.S. ALCOHOL TESTING AND GOOD IDEAS ENTERPRISES ANNOUNCE INTENT FOR INITIAL PUBLIC OFFERING OF GOOD IDEAS
U.S. ALCOHOL ANNOUNCES LETTER OF INTENT WITH SUBSIDIARY OF GTECH CORP.
U.S. ALCOHOL TESTING ANNOUNCES ENGINEERING AGREEMENT IN CONNECTION WITH DEVELOPMENT OF SALIVA BASED DRUG TEST OF U.S. DRUG TESTING SUBSIDIARY
CONSOLIDATED MERCANTILE CORPORATION ANNOUNCES LETTER OF INTENT
U.S. ALCOHOL TESTING OF AMERICA, INC. TO SELL U.S. RUBBER RECYCLING SUBSIDIARY
NYER MEDICAL GROUP, INC. ANNOUNCES THAT GENETIC VECTORS, INC. SIGNS LETTER OF INTENT FOR INITIAL PUBLIC OFFERING
Baxter International Enhances Distribution Channels.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters